Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
5
×
boston blog main
boston top stories
clinical trials
fda
5
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
novartis
5
×
biotech
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
eli lilly
abeona therapeutics
alnylam pharmaceuticals
astrazeneca
avexis
brian kaspar
centers for disease control and prevention
deals
gene therapy
What
fda
roundup
bio
biotech
drug
medicines
new
news
won
according
acquire
agreed
akcea
alzheimer’s
amgen
approval
august
billion
brings
busy
candidates
cases
cash
centers
cholesterol
cigarettes
class
company
compound
congress
control
days
deal
deaths
decisions
democrats
developed
devices
disease
divided
Language
unset
Current search:
novartis
×
amgen
×
fda
×
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel
@xconomy.com
6 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines
